Member Info for Kevinl1977

Yes, if we can recover to 30p we will be back where we were last month without any news.
Keep smiling.

External funding and collaboration with Jansen is good news.
‘As an observational study, no treatments are being investigated.’

Mani
Of course.
I also played with and against many who didn’t have the ability and eventually got found out.
There were of course those who snook under the parapet and pinched a living for a while, too.
However, this is not about me.
It’s about the ability of a team that apparently know it works. Yet, we now know it only has limited success with a small sub group.
Hence, my change of mindset.
Sorry if this upsets your philosophy and mindset.

Gunto
When did I say it was anyone else’s fault?
Difference is, I don’t continue to ramp this Company. It failed, move on!
Only an idiot throws good money after bad.
Yes, I know that will produce several responses from posters saying the word ‘Polygon.’

Gunto
At least you admit that they failed.
Pls tell me what I’m invested in?
According to many of the Rampers on here nothing has changed.
Honesty and realism Gunto!

A little bit of speculation and we jump all over it.
Maybe we will be able to treat the over 60’s that get sick. Oh, almost forgot, we haven’t got approval to use our drug.
Never mind, another presentation of the same facts should do us all good.
We can all look out for the grins or smiles that come our way and spend hours trying to ascertain what they meant.
Keep smiling.

Old trader
This happened most times that Synairgen produced a positive RNS.
My take is that the timeline is 2/3 months away from the data readout, which seems to result in a drop. Still plenty of volume being snatched up.
Same theory for me; if you believe in the science then keep buying at bargain prices.
Only thing is, this theory bit me on the bum with Synairgen.
Second time lucky for me!

Fazer
That comment about you haven’t lost anything until you sell is rubbish.
If someone asks what assets you have currently what would you say?
I have this, that, I also have x number of Synairgen shares. They would say what are they worth? Would you say £2 a share or 0.20p a share?
It’s a ‘when it suits’ type of response to try and negate disappointment.

This is part of her role, to provide responses to investors, etc.
I’m guessing the SP will go up another 2-4% on the back of this.

Mayta
Thanks for the response.

Mayt
Thanks for the reply.
What about the small figure quoted?
If this is breakthrough, surely multiplies of this number are expected?

Good RNS
Referring to the text from the RNS:
‘agent, with a market size that is expected to grow to $1.38bn by 2024[1], are widely used as part of standard of care in several tumour types, but its use is limited by cumulative dose toxicity associated with cardiomyopathy’
The figure of 1.38b is pretty low, any help as to why?
Use is limited? Will this affect ability to bring the drug to the market?
Ideas greatly appreciated.

Stupidity and ridiculous ramping at its best.
You criticise others for deramping and then do the same.
I’m getting the word …..

Idiot!

Mani
Who gives a flying f…
The SP has lost 90% of its value, due to the failed trial.
Volume is awful.
SP is awful.

https://www.lse.co.uk/rns/SNG/full-year-results-t81k58xq3ffu0on.html
Full Year results
Who are syairgen?

The arguments continue on here because everyone is guessing what is happening behind the scenes.
I think we’ve been here many times before.
Maybe, a brief supporting video from our CEO explaining significant attendees at the AGM or an explanation regarding the further lines of enquiry that have been made, etc.
This is part of his role.
He is failing to fulfil his role, FACT.
It could be worse; the SP could be disastrous.

Discussed this before, NO.

What like when we get RNSs and our own communications officer gets her email address wrong!
As I said, amateurish.

Ghia
This individual is the elected representative of the board to protect the interest of the investors and shareholders.
Completely agree.
Tommy
Some people are never happy.
How can any investor be happy holding this share? The Company is amateurish, at best. Appalling communication, a plan of ‘ifs’.
Never brought a drug to the market and never will imo, especially under the guidance of RM.
We were sold a dream which never materialised and the who wouldn’t have been pulled in with the ‘we know it works’ and top hires of various execs, etc.
Rampers on here are repeating the same rubbish we have been listening to for well over 2 years.
The SP is disastrous and will only get worse.
The summer ends in 4 weeks and the apparent feedback from A2 will be beyond ridiculous.
If the results were worth sharing, they would have been.
What a load of nonsense.